Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RSR Ltd is a specialized biotechnology company focused on the development and manufacture of high-performance medical diagnostic kits for autoimmune diseases. Based in Cardiff, UK, the company is a global leader in the field of immunodiagnostics, particularly for thyroid disorders, type 1 diabetes, and neurological conditions. RSR's portfolio includes gold-standard assays for detecting autoantibodies against the TSH receptor, glutamate decarboxylase (GAD), and the acetylcholine receptor. These products are essential for the clinical diagnosis and management of conditions such as Graves' disease, myasthenia gravis, and neuromyelitis optica. The company maintains a strong research and development program, leveraging expertise in recombinant protein expression and monoclonal antibody technology to improve diagnostic accuracy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RSR Healthcare.